Venus Remedies launches comprehensive family medical insurance policy for all employees under ‘Venus Care’ initiative

CHANDIGARH:  Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has introduced a comprehensive Family Medical Insurance Policy for all employees under its flagship employee wellbeing initiative, Venus Care. Reinforcing the company’s commitment to creating a secure, supportive, and empowering work environment, the policy will extend medical coverage to over 856 employees and will cover insurance for the new joiners from the very first day of their employment.

With a deep sense of responsibility towards the families of its workforce, Venus Remedies has designed the policy to include each employee’s spouse and up to two children. Through a group insurance plan offering annual medical benefits worth INR 5 lacs per family, the initiative covers services such as cashless hospitalization, daycare procedures, reimbursement facilities, coverage for pre-existing diseases, fastest claim processing through TPA, OPD support, accessible across a wide network of hospitals. The company is investing approximately INR 74 lacs in this initiative, underlining its people-first philosophy and recognition of healthcare as a core pillar of employee security and satisfaction.

“At Venus Remedies, we believe that true employee well-being begins with feeling secure—physically, emotionally, and mentally. Our new healthcare initiative reflects this belief by extending care beyond the individual to their families. When employees know their loved ones are protected, it nurtures a sense of trust and belonging that strengthens focus, resilience, and loyalty. For us, care isn’t just a benefit—it’s the foundation of our culture,” said Mr. Akshansh Chaudhary, Executive Director & Chief Technology Officer, Venus Remedies. 

This effort is part of the company’s broader focus on inclusive growth and progressive HR policies that align with global best practices. Venus Remedies has consistently led the way in employee engagement and was recently recognised as a Great Place to Work (2025) for the fourth consecutive year. The company has also demonstrated its commitment to workforce development through its 2024 partnership with the National Skill Development Corporation (NSDC), under which 128 employees across 30 departments participated in a pioneering skill certification programme.

This initiative aims to build a future-ready workforce by enhancing competencies, promoting lifelong learning, and linking skill certification to career progression and leadership pathways within the company.

As a global leader in affordable generics and R&D-driven pharma innovation and renowned for its longstanding expertise in combatting antimicrobial resistance (AMR), Venus Remedies continues to foster a culture of care, learning, and empowerment—cementing its position as an employer of choice for the future-ready Indian workforce. 

About Venus Remedies

Panchkula-based Venus Remedies Ltd (NSE: VENUSREM, BSE: 526953) is among the 10 leading fixed-dosage injectable manufacturers in the world. Having a commercial presence in 80+ countries with a portfolio of 75 products spread over Europe, Australia, Africa, Asia-Pacific, Commonwealth States, the Middle East, Latin America and the Caribbean region, the company has nine globally benchmarked facilities in Panchkula, Baddi and Werne (Germany), apart from 11 overseas marketing offices. Its manufacturing units are certified for ISO 9001, ISO 14001, ISO 18001 and OHSAS.

The company has also been approved by European- GMP, WHO-GMP and Latin American GMP (INVIMA), among others. Ranked 107th in Asia and among the world’s 500 largest pharmaceutical manufacturing companies, Venus Remedies has been granted more than 130 patents worldwide and having more than 75 registered trademarks and more than 15 copyrights for its innovative research products. Moreover, in 2025, Venus Remedies received recognition as a ‘Great Place to Work’ for the fourth consecutive time.